Director/PDMR Shareholding

RNS Number : 3258I

Epistem Holdings plc

01 July 2013

 



Epistem Plc ("Epistem" or the "Company")

Directors' Shareholdings

Epistem today provides an update regarding the Company's share investment plan, details of which were announced on 13 July 2009.

As a result of the subscription for Partnership Shares and the award of Matching Shares, the executive Directors each increased their beneficial interests in the Company by 198 ordinary shares of 1.5p each. These shares were acquired on 30^th April 2013, 13^th June 2013 and 28^th June 2013 at prices of 565p, 580p and 580p respectively.

Following these transactions, the current beneficial interests of the executive Directors are set out below:

                                                Ordinary Shares                       %

Matthew Walls                           10,372                                    0.11%

Dr Catherine Booth                  984,727                                  10.17%

Dr Jeffrey Moore                       14,052                                    0.15%

John Rylands                            194,625                                    2.01%

For further details please contact:

Epistem Plc

Matthew Walls, CEO                                                               [phone]

John Rylands, Finance Director                                                 [phone]

Peel Hunt LLP

James Steel /Vijay Barathan                                                      [phone]

 

END

 

 

RDSBUGDRDGGBGXB